High level of depressive symptoms as a barrier to reach an ideal cardiovascular health. The Paris Prospective Study III
We hypothesized that depression might represent a barrier to reach an ideal cardiovascular health (CVH) as estimated by the 7-item tool proposed by the American Heart Association. Between 2008 and 2012, 9,417 subjects 50–75 years of age were examined in a large health center and enrolled in the Pari...
Gespeichert in:
| Veröffentlicht in: | Scientific reports 2016-01, Vol.6 (1), p.18951-18951, Article 18951 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 18951 |
|---|---|
| container_issue | 1 |
| container_start_page | 18951 |
| container_title | Scientific reports |
| container_volume | 6 |
| creator | Gaye, B. Prugger, C. Perier, M. C. Thomas, F. Plichart, M. Guibout, C. Lemogne, C. Pannier, B. Boutouyrie, P. Jouven, X. Empana, J. P. |
| description | We hypothesized that depression might represent a barrier to reach an ideal cardiovascular health (CVH) as estimated by the 7-item tool proposed by the American Heart Association. Between 2008 and 2012, 9,417 subjects 50–75 years of age were examined in a large health center and enrolled in the Paris Prospective Study III (PPS3). Participants with 0–2, 3–4 and 5–7 health metrics at the ideal level were categorized as having poor, intermediate and ideal CVH, respectively. Participants with a score ≥7 on the 13-item Questionnaire of Depression 2nd version, Abridged or who were on antidepressants were referred as having high level of depressive symptoms (HLDS). The mean age of the 9417 study participants was 59.57 (SD 6.28) years and 61.16% were males. A total of 9.55% had HLDS. Poor, intermediate and ideal CVH was present in 40.38%, 49.52% and 10.10% of the participants. In multivariate polytomous logistic regression analysis, HLDS was inversely associated with ideal CVH (odds ratio = 0.70; 95% CI: 0.55;0.90). This was driven by an association with the behavioural component of the CVH. Participants with HLDS had a substantial reduced chance of reaching an ideal CVH. |
| doi_str_mv | 10.1038/srep18951 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4705528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1760886152</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-66f3aaaf5b571908d04188868600c582de1d3df061ff86cc5872f98c782f4ec63</originalsourceid><addsrcrecordid>eNplkV1rFDEUhoMottRe-Ack4I0WtuZzJnMjlGLdhQUL1uuQzZzspMxMxmRmZP-9Wbauaw2BhHOevOfkvAi9peSaEq4-pQgDVZWkL9A5I0IuGGfs5cn9DF2m9EjykqwStHqNzlhRCs6pOke_ln7b4BZmaHFwuIYhQkp-Bpx23TCGLmGTN96YGD1EPAYcwdgGmx77GkyLrYm1D7NJdmpNxE2Ojc01fmgA35voE76PIQ1gx73o93Gqd3i1Wr1Br5xpE1w-nRfox92Xh9vlYv3t6-r2Zr2wkqtxURSOG2Oc3MiSVkTVRFClVKEKQqxUrAZa89qRgjqnCptDJXOVsqViToAt-AX6fNAdpk0HtYV-jKbVQ_SdiTsdjNf_Znrf6G2YtSiJlExlgY8HgebZs-XNWu9jRDAhKkVmmtkPT8Vi-DlBGnXnk4W2NT2EKWlaFiQ3TyXL6Ptn6GOYYp9HobOZVTa2LPnf4jbPMBvtjh1Qovfu66P7mX13-tMj-cfrDFwdgJRT_RbiScn_1H4D5MO4sw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899038773</pqid></control><display><type>article</type><title>High level of depressive symptoms as a barrier to reach an ideal cardiovascular health. The Paris Prospective Study III</title><source>MEDLINE</source><source>Nature Free</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature OA Free Journals</source><creator>Gaye, B. ; Prugger, C. ; Perier, M. C. ; Thomas, F. ; Plichart, M. ; Guibout, C. ; Lemogne, C. ; Pannier, B. ; Boutouyrie, P. ; Jouven, X. ; Empana, J. P.</creator><creatorcontrib>Gaye, B. ; Prugger, C. ; Perier, M. C. ; Thomas, F. ; Plichart, M. ; Guibout, C. ; Lemogne, C. ; Pannier, B. ; Boutouyrie, P. ; Jouven, X. ; Empana, J. P.</creatorcontrib><description>We hypothesized that depression might represent a barrier to reach an ideal cardiovascular health (CVH) as estimated by the 7-item tool proposed by the American Heart Association. Between 2008 and 2012, 9,417 subjects 50–75 years of age were examined in a large health center and enrolled in the Paris Prospective Study III (PPS3). Participants with 0–2, 3–4 and 5–7 health metrics at the ideal level were categorized as having poor, intermediate and ideal CVH, respectively. Participants with a score ≥7 on the 13-item Questionnaire of Depression 2nd version, Abridged or who were on antidepressants were referred as having high level of depressive symptoms (HLDS). The mean age of the 9417 study participants was 59.57 (SD 6.28) years and 61.16% were males. A total of 9.55% had HLDS. Poor, intermediate and ideal CVH was present in 40.38%, 49.52% and 10.10% of the participants. In multivariate polytomous logistic regression analysis, HLDS was inversely associated with ideal CVH (odds ratio = 0.70; 95% CI: 0.55;0.90). This was driven by an association with the behavioural component of the CVH. Participants with HLDS had a substantial reduced chance of reaching an ideal CVH.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/srep18951</identifier><identifier>PMID: 26743318</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308/174 ; 692/499 ; 692/699/75 ; 692/700/459 ; Aged ; Antidepressants ; Antidepressive Agents - therapeutic use ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - physiopathology ; Cross-Sectional Studies ; Depression - complications ; Depression - diagnosis ; Depression - drug therapy ; Depression - physiopathology ; Female ; France ; Health risk assessment ; Health Status ; Humanities and Social Sciences ; Humans ; Life Sciences ; Male ; Mental depression ; Middle Aged ; multidisciplinary ; Odds Ratio ; Prognosis ; Prospective Studies ; Regression analysis ; Risk Assessment ; Science ; Surveys and Questionnaires</subject><ispartof>Scientific reports, 2016-01, Vol.6 (1), p.18951-18951, Article 18951</ispartof><rights>The Author(s) 2016</rights><rights>Copyright Nature Publishing Group Jan 2016</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Copyright © 2016, Macmillan Publishers Limited 2016 Macmillan Publishers Limited</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-66f3aaaf5b571908d04188868600c582de1d3df061ff86cc5872f98c782f4ec63</citedby><cites>FETCH-LOGICAL-c538t-66f3aaaf5b571908d04188868600c582de1d3df061ff86cc5872f98c782f4ec63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705528/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705528/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26743318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04244980$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Gaye, B.</creatorcontrib><creatorcontrib>Prugger, C.</creatorcontrib><creatorcontrib>Perier, M. C.</creatorcontrib><creatorcontrib>Thomas, F.</creatorcontrib><creatorcontrib>Plichart, M.</creatorcontrib><creatorcontrib>Guibout, C.</creatorcontrib><creatorcontrib>Lemogne, C.</creatorcontrib><creatorcontrib>Pannier, B.</creatorcontrib><creatorcontrib>Boutouyrie, P.</creatorcontrib><creatorcontrib>Jouven, X.</creatorcontrib><creatorcontrib>Empana, J. P.</creatorcontrib><title>High level of depressive symptoms as a barrier to reach an ideal cardiovascular health. The Paris Prospective Study III</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>We hypothesized that depression might represent a barrier to reach an ideal cardiovascular health (CVH) as estimated by the 7-item tool proposed by the American Heart Association. Between 2008 and 2012, 9,417 subjects 50–75 years of age were examined in a large health center and enrolled in the Paris Prospective Study III (PPS3). Participants with 0–2, 3–4 and 5–7 health metrics at the ideal level were categorized as having poor, intermediate and ideal CVH, respectively. Participants with a score ≥7 on the 13-item Questionnaire of Depression 2nd version, Abridged or who were on antidepressants were referred as having high level of depressive symptoms (HLDS). The mean age of the 9417 study participants was 59.57 (SD 6.28) years and 61.16% were males. A total of 9.55% had HLDS. Poor, intermediate and ideal CVH was present in 40.38%, 49.52% and 10.10% of the participants. In multivariate polytomous logistic regression analysis, HLDS was inversely associated with ideal CVH (odds ratio = 0.70; 95% CI: 0.55;0.90). This was driven by an association with the behavioural component of the CVH. Participants with HLDS had a substantial reduced chance of reaching an ideal CVH.</description><subject>692/308/174</subject><subject>692/499</subject><subject>692/699/75</subject><subject>692/700/459</subject><subject>Aged</subject><subject>Antidepressants</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cardiovascular Diseases - physiopathology</subject><subject>Cross-Sectional Studies</subject><subject>Depression - complications</subject><subject>Depression - diagnosis</subject><subject>Depression - drug therapy</subject><subject>Depression - physiopathology</subject><subject>Female</subject><subject>France</subject><subject>Health risk assessment</subject><subject>Health Status</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Mental depression</subject><subject>Middle Aged</subject><subject>multidisciplinary</subject><subject>Odds Ratio</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Regression analysis</subject><subject>Risk Assessment</subject><subject>Science</subject><subject>Surveys and Questionnaires</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNplkV1rFDEUhoMottRe-Ack4I0WtuZzJnMjlGLdhQUL1uuQzZzspMxMxmRmZP-9Wbauaw2BhHOevOfkvAi9peSaEq4-pQgDVZWkL9A5I0IuGGfs5cn9DF2m9EjykqwStHqNzlhRCs6pOke_ln7b4BZmaHFwuIYhQkp-Bpx23TCGLmGTN96YGD1EPAYcwdgGmx77GkyLrYm1D7NJdmpNxE2Ojc01fmgA35voE76PIQ1gx73o93Gqd3i1Wr1Br5xpE1w-nRfox92Xh9vlYv3t6-r2Zr2wkqtxURSOG2Oc3MiSVkTVRFClVKEKQqxUrAZa89qRgjqnCptDJXOVsqViToAt-AX6fNAdpk0HtYV-jKbVQ_SdiTsdjNf_Znrf6G2YtSiJlExlgY8HgebZs-XNWu9jRDAhKkVmmtkPT8Vi-DlBGnXnk4W2NT2EKWlaFiQ3TyXL6Ptn6GOYYp9HobOZVTa2LPnf4jbPMBvtjh1Qovfu66P7mX13-tMj-cfrDFwdgJRT_RbiScn_1H4D5MO4sw</recordid><startdate>20160108</startdate><enddate>20160108</enddate><creator>Gaye, B.</creator><creator>Prugger, C.</creator><creator>Perier, M. C.</creator><creator>Thomas, F.</creator><creator>Plichart, M.</creator><creator>Guibout, C.</creator><creator>Lemogne, C.</creator><creator>Pannier, B.</creator><creator>Boutouyrie, P.</creator><creator>Jouven, X.</creator><creator>Empana, J. P.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope></search><sort><creationdate>20160108</creationdate><title>High level of depressive symptoms as a barrier to reach an ideal cardiovascular health. The Paris Prospective Study III</title><author>Gaye, B. ; Prugger, C. ; Perier, M. C. ; Thomas, F. ; Plichart, M. ; Guibout, C. ; Lemogne, C. ; Pannier, B. ; Boutouyrie, P. ; Jouven, X. ; Empana, J. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-66f3aaaf5b571908d04188868600c582de1d3df061ff86cc5872f98c782f4ec63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>692/308/174</topic><topic>692/499</topic><topic>692/699/75</topic><topic>692/700/459</topic><topic>Aged</topic><topic>Antidepressants</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cardiovascular Diseases - physiopathology</topic><topic>Cross-Sectional Studies</topic><topic>Depression - complications</topic><topic>Depression - diagnosis</topic><topic>Depression - drug therapy</topic><topic>Depression - physiopathology</topic><topic>Female</topic><topic>France</topic><topic>Health risk assessment</topic><topic>Health Status</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Mental depression</topic><topic>Middle Aged</topic><topic>multidisciplinary</topic><topic>Odds Ratio</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Regression analysis</topic><topic>Risk Assessment</topic><topic>Science</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gaye, B.</creatorcontrib><creatorcontrib>Prugger, C.</creatorcontrib><creatorcontrib>Perier, M. C.</creatorcontrib><creatorcontrib>Thomas, F.</creatorcontrib><creatorcontrib>Plichart, M.</creatorcontrib><creatorcontrib>Guibout, C.</creatorcontrib><creatorcontrib>Lemogne, C.</creatorcontrib><creatorcontrib>Pannier, B.</creatorcontrib><creatorcontrib>Boutouyrie, P.</creatorcontrib><creatorcontrib>Jouven, X.</creatorcontrib><creatorcontrib>Empana, J. P.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gaye, B.</au><au>Prugger, C.</au><au>Perier, M. C.</au><au>Thomas, F.</au><au>Plichart, M.</au><au>Guibout, C.</au><au>Lemogne, C.</au><au>Pannier, B.</au><au>Boutouyrie, P.</au><au>Jouven, X.</au><au>Empana, J. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High level of depressive symptoms as a barrier to reach an ideal cardiovascular health. The Paris Prospective Study III</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2016-01-08</date><risdate>2016</risdate><volume>6</volume><issue>1</issue><spage>18951</spage><epage>18951</epage><pages>18951-18951</pages><artnum>18951</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>We hypothesized that depression might represent a barrier to reach an ideal cardiovascular health (CVH) as estimated by the 7-item tool proposed by the American Heart Association. Between 2008 and 2012, 9,417 subjects 50–75 years of age were examined in a large health center and enrolled in the Paris Prospective Study III (PPS3). Participants with 0–2, 3–4 and 5–7 health metrics at the ideal level were categorized as having poor, intermediate and ideal CVH, respectively. Participants with a score ≥7 on the 13-item Questionnaire of Depression 2nd version, Abridged or who were on antidepressants were referred as having high level of depressive symptoms (HLDS). The mean age of the 9417 study participants was 59.57 (SD 6.28) years and 61.16% were males. A total of 9.55% had HLDS. Poor, intermediate and ideal CVH was present in 40.38%, 49.52% and 10.10% of the participants. In multivariate polytomous logistic regression analysis, HLDS was inversely associated with ideal CVH (odds ratio = 0.70; 95% CI: 0.55;0.90). This was driven by an association with the behavioural component of the CVH. Participants with HLDS had a substantial reduced chance of reaching an ideal CVH.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>26743318</pmid><doi>10.1038/srep18951</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2045-2322 |
| ispartof | Scientific reports, 2016-01, Vol.6 (1), p.18951-18951, Article 18951 |
| issn | 2045-2322 2045-2322 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4705528 |
| source | MEDLINE; Nature Free; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry; Springer Nature OA Free Journals |
| subjects | 692/308/174 692/499 692/699/75 692/700/459 Aged Antidepressants Antidepressive Agents - therapeutic use Cardiovascular Diseases - diagnosis Cardiovascular Diseases - etiology Cardiovascular Diseases - physiopathology Cross-Sectional Studies Depression - complications Depression - diagnosis Depression - drug therapy Depression - physiopathology Female France Health risk assessment Health Status Humanities and Social Sciences Humans Life Sciences Male Mental depression Middle Aged multidisciplinary Odds Ratio Prognosis Prospective Studies Regression analysis Risk Assessment Science Surveys and Questionnaires |
| title | High level of depressive symptoms as a barrier to reach an ideal cardiovascular health. The Paris Prospective Study III |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T00%3A44%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20level%20of%20depressive%20symptoms%20as%20a%20barrier%20to%20reach%20an%20ideal%20cardiovascular%20health.%20The%20Paris%20Prospective%20Study%20III&rft.jtitle=Scientific%20reports&rft.au=Gaye,%20B.&rft.date=2016-01-08&rft.volume=6&rft.issue=1&rft.spage=18951&rft.epage=18951&rft.pages=18951-18951&rft.artnum=18951&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/srep18951&rft_dat=%3Cproquest_pubme%3E1760886152%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1899038773&rft_id=info:pmid/26743318&rfr_iscdi=true |